Daniel Salazar
Directeur/Membre du Conseil chez Vero Biotech LLC
Profil
Daniel E.
Salazar has held multiple positions throughout his career.
Currently, he is the Director at Vero Biotech LLC.
He is also the Vice President and Director at Brace Pharmaceuticals, Inc. since 2015, and the Vice President at Daiichi Sankyo, Inc. since 2006.
In terms of education, Dr. Salazar completed his undergraduate degree at Princeton University in 1974 and obtained his doctorate degree from the University At Buffalo in 1989.
Postes actifs de Daniel Salazar
| Sociétés | Poste | Début |
|---|---|---|
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Directeur/Membre du Conseil | - |
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Directeur/Membre du Conseil | 01/02/2015 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Private Equity Investor | 01/04/2006 |
Formation de Daniel Salazar
| University At Buffalo | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | Health Technology |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | Finance |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
